malignant melanoma cell lines Search Results


human metastatic malignant melanoma cell line wm-266-4  (Korean Cell Line Bank)
90
Korean Cell Line Bank human metastatic malignant melanoma cell line wm-266-4
Human Metastatic Malignant Melanoma Cell Line Wm 266 4, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human metastatic malignant melanoma cell line wm-266-4/product/Korean Cell Line Bank
Average 90 stars, based on 1 article reviews
human metastatic malignant melanoma cell line wm-266-4 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
a375 malignant melanoma cell line  (Ubigene Biosciences Co Ltd)
90
Ubigene Biosciences Co Ltd a375 malignant melanoma cell line
Specificity of Enrichment of PolyLacNAc-Containing Glycopeptide of Anion Exchange Columns from <t> A375 </t> Cell Lysates <xref ref-type= a " width="250" height="auto" />
A375 Malignant Melanoma Cell Line, supplied by Ubigene Biosciences Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/a375 malignant melanoma cell line/product/Ubigene Biosciences Co Ltd
Average 90 stars, based on 1 article reviews
a375 malignant melanoma cell line - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
cell human malignant melanoma cells (mewo) line  (European Collection of Authenticated Cell Cultures)
90
European Collection of Authenticated Cell Cultures cell human malignant melanoma cells (mewo) line
Specificity of Enrichment of PolyLacNAc-Containing Glycopeptide of Anion Exchange Columns from <t> A375 </t> Cell Lysates <xref ref-type= a " width="250" height="auto" />
Cell Human Malignant Melanoma Cells (Mewo) Line, supplied by European Collection of Authenticated Cell Cultures, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell human malignant melanoma cells (mewo) line/product/European Collection of Authenticated Cell Cultures
Average 90 stars, based on 1 article reviews
cell human malignant melanoma cells (mewo) line - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
human malignant melanoma cell lines  (Gallus BioPharmaceuticals)
90
Gallus BioPharmaceuticals human malignant melanoma cell lines
Specificity of Enrichment of PolyLacNAc-Containing Glycopeptide of Anion Exchange Columns from <t> A375 </t> Cell Lysates <xref ref-type= a " width="250" height="auto" />
Human Malignant Melanoma Cell Lines, supplied by Gallus BioPharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human malignant melanoma cell lines/product/Gallus BioPharmaceuticals
Average 90 stars, based on 1 article reviews
human malignant melanoma cell lines - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
sk-mel-5 (malignant melanoma  (Korean Cell Line Bank)
90
Korean Cell Line Bank sk-mel-5 (malignant melanoma
In vitro and in vivo functionality of A56-specific A56 CAR-T cells (A) Real-time cytotoxicity of A56 CAR-T cells against HCT-116 cells infected with 0.05 MOI of OTS-412. (B) Quantification of A56 CAR-T cell cytotoxicity in various human cancer cell lines infected with OTS-412. (∗∗∗ p < 0.001, comparison of T cell groups; n = 2 for A549, HCT-116, HeLa, <t>SK-MEL-5</t> and n = 3 for MCF7 and PC-3 by two-tailed unpaired t test). Data are represented as the mean value ± SEM. (C) Aggregation of A56 CAR-T cells targeting tumor cells observed every 12 h until day 4 in real-time. (D) Antigen-dependent anti-tumor efficacy of A56 CAR-T cells in HCT-116 tumor-bearing mice after intratumoral T cell injection following OTS-412 injection with or without HU (∗ p < 0.05, ∗∗ p < 0.01, comparison of T cell groups; saline, n = 5; treatment groups, n = 4, two-way ANOVA with multiple comparison). Data are represented as the mean value ± SD. (E) IHC analysis of A56 expression and infiltrated hCD3 + T cells in tumors isolated from HCT-116 tumor-bearing mice 21 days post-intravenous T cell treatment. Scale bar, 20 μm (left panel) and quantitation of tumor-infiltrating A56 CAR-T cells positive for hCD3 (right panel) (∗ p = 0.01, n = 3, two-tailed unpaired t test). Data are presented as the mean ± SD. MOI, multiplicity of infection; IHC, immunohistochemistry.
Sk Mel 5 (Malignant Melanoma, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sk-mel-5 (malignant melanoma/product/Korean Cell Line Bank
Average 90 stars, based on 1 article reviews
sk-mel-5 (malignant melanoma - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
femx1-gfp  (Anticancer Inc)
90
Anticancer Inc femx1-gfp
In vitro and in vivo functionality of A56-specific A56 CAR-T cells (A) Real-time cytotoxicity of A56 CAR-T cells against HCT-116 cells infected with 0.05 MOI of OTS-412. (B) Quantification of A56 CAR-T cell cytotoxicity in various human cancer cell lines infected with OTS-412. (∗∗∗ p < 0.001, comparison of T cell groups; n = 2 for A549, HCT-116, HeLa, <t>SK-MEL-5</t> and n = 3 for MCF7 and PC-3 by two-tailed unpaired t test). Data are represented as the mean value ± SEM. (C) Aggregation of A56 CAR-T cells targeting tumor cells observed every 12 h until day 4 in real-time. (D) Antigen-dependent anti-tumor efficacy of A56 CAR-T cells in HCT-116 tumor-bearing mice after intratumoral T cell injection following OTS-412 injection with or without HU (∗ p < 0.05, ∗∗ p < 0.01, comparison of T cell groups; saline, n = 5; treatment groups, n = 4, two-way ANOVA with multiple comparison). Data are represented as the mean value ± SD. (E) IHC analysis of A56 expression and infiltrated hCD3 + T cells in tumors isolated from HCT-116 tumor-bearing mice 21 days post-intravenous T cell treatment. Scale bar, 20 μm (left panel) and quantitation of tumor-infiltrating A56 CAR-T cells positive for hCD3 (right panel) (∗ p = 0.01, n = 3, two-tailed unpaired t test). Data are presented as the mean ± SD. MOI, multiplicity of infection; IHC, immunohistochemistry.
Femx1 Gfp, supplied by Anticancer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/femx1-gfp/product/Anticancer Inc
Average 90 stars, based on 1 article reviews
femx1-gfp - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
human malme-3m malignant melanoma cell line  (Charles River Laboratories)
90
Charles River Laboratories human malme-3m malignant melanoma cell line
In vitro and in vivo functionality of A56-specific A56 CAR-T cells (A) Real-time cytotoxicity of A56 CAR-T cells against HCT-116 cells infected with 0.05 MOI of OTS-412. (B) Quantification of A56 CAR-T cell cytotoxicity in various human cancer cell lines infected with OTS-412. (∗∗∗ p < 0.001, comparison of T cell groups; n = 2 for A549, HCT-116, HeLa, <t>SK-MEL-5</t> and n = 3 for MCF7 and PC-3 by two-tailed unpaired t test). Data are represented as the mean value ± SEM. (C) Aggregation of A56 CAR-T cells targeting tumor cells observed every 12 h until day 4 in real-time. (D) Antigen-dependent anti-tumor efficacy of A56 CAR-T cells in HCT-116 tumor-bearing mice after intratumoral T cell injection following OTS-412 injection with or without HU (∗ p < 0.05, ∗∗ p < 0.01, comparison of T cell groups; saline, n = 5; treatment groups, n = 4, two-way ANOVA with multiple comparison). Data are represented as the mean value ± SD. (E) IHC analysis of A56 expression and infiltrated hCD3 + T cells in tumors isolated from HCT-116 tumor-bearing mice 21 days post-intravenous T cell treatment. Scale bar, 20 μm (left panel) and quantitation of tumor-infiltrating A56 CAR-T cells positive for hCD3 (right panel) (∗ p = 0.01, n = 3, two-tailed unpaired t test). Data are presented as the mean ± SD. MOI, multiplicity of infection; IHC, immunohistochemistry.
Human Malme 3m Malignant Melanoma Cell Line, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human malme-3m malignant melanoma cell line/product/Charles River Laboratories
Average 90 stars, based on 1 article reviews
human malme-3m malignant melanoma cell line - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
femx-i human malignant melanoma hla-a*02:01 positive cell line  (Eppendorf AG)
90
Eppendorf AG femx-i human malignant melanoma hla-a*02:01 positive cell line
In vitro and in vivo functionality of A56-specific A56 CAR-T cells (A) Real-time cytotoxicity of A56 CAR-T cells against HCT-116 cells infected with 0.05 MOI of OTS-412. (B) Quantification of A56 CAR-T cell cytotoxicity in various human cancer cell lines infected with OTS-412. (∗∗∗ p < 0.001, comparison of T cell groups; n = 2 for A549, HCT-116, HeLa, <t>SK-MEL-5</t> and n = 3 for MCF7 and PC-3 by two-tailed unpaired t test). Data are represented as the mean value ± SEM. (C) Aggregation of A56 CAR-T cells targeting tumor cells observed every 12 h until day 4 in real-time. (D) Antigen-dependent anti-tumor efficacy of A56 CAR-T cells in HCT-116 tumor-bearing mice after intratumoral T cell injection following OTS-412 injection with or without HU (∗ p < 0.05, ∗∗ p < 0.01, comparison of T cell groups; saline, n = 5; treatment groups, n = 4, two-way ANOVA with multiple comparison). Data are represented as the mean value ± SD. (E) IHC analysis of A56 expression and infiltrated hCD3 + T cells in tumors isolated from HCT-116 tumor-bearing mice 21 days post-intravenous T cell treatment. Scale bar, 20 μm (left panel) and quantitation of tumor-infiltrating A56 CAR-T cells positive for hCD3 (right panel) (∗ p = 0.01, n = 3, two-tailed unpaired t test). Data are presented as the mean ± SD. MOI, multiplicity of infection; IHC, immunohistochemistry.
Femx I Human Malignant Melanoma Hla A*02:01 Positive Cell Line, supplied by Eppendorf AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/femx-i human malignant melanoma hla-a*02:01 positive cell line/product/Eppendorf AG
Average 90 stars, based on 1 article reviews
femx-i human malignant melanoma hla-a*02:01 positive cell line - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
human malignant melanoma a375 cell lines  (Servicebio Inc)
90
Servicebio Inc human malignant melanoma a375 cell lines
In vitro and in vivo functionality of A56-specific A56 CAR-T cells (A) Real-time cytotoxicity of A56 CAR-T cells against HCT-116 cells infected with 0.05 MOI of OTS-412. (B) Quantification of A56 CAR-T cell cytotoxicity in various human cancer cell lines infected with OTS-412. (∗∗∗ p < 0.001, comparison of T cell groups; n = 2 for A549, HCT-116, HeLa, <t>SK-MEL-5</t> and n = 3 for MCF7 and PC-3 by two-tailed unpaired t test). Data are represented as the mean value ± SEM. (C) Aggregation of A56 CAR-T cells targeting tumor cells observed every 12 h until day 4 in real-time. (D) Antigen-dependent anti-tumor efficacy of A56 CAR-T cells in HCT-116 tumor-bearing mice after intratumoral T cell injection following OTS-412 injection with or without HU (∗ p < 0.05, ∗∗ p < 0.01, comparison of T cell groups; saline, n = 5; treatment groups, n = 4, two-way ANOVA with multiple comparison). Data are represented as the mean value ± SD. (E) IHC analysis of A56 expression and infiltrated hCD3 + T cells in tumors isolated from HCT-116 tumor-bearing mice 21 days post-intravenous T cell treatment. Scale bar, 20 μm (left panel) and quantitation of tumor-infiltrating A56 CAR-T cells positive for hCD3 (right panel) (∗ p = 0.01, n = 3, two-tailed unpaired t test). Data are presented as the mean ± SD. MOI, multiplicity of infection; IHC, immunohistochemistry.
Human Malignant Melanoma A375 Cell Lines, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human malignant melanoma a375 cell lines/product/Servicebio Inc
Average 90 stars, based on 1 article reviews
human malignant melanoma a375 cell lines - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
human malignant melanoma cell lines  (North American Biologicals Inc)
90
North American Biologicals Inc human malignant melanoma cell lines
In vitro and in vivo functionality of A56-specific A56 CAR-T cells (A) Real-time cytotoxicity of A56 CAR-T cells against HCT-116 cells infected with 0.05 MOI of OTS-412. (B) Quantification of A56 CAR-T cell cytotoxicity in various human cancer cell lines infected with OTS-412. (∗∗∗ p < 0.001, comparison of T cell groups; n = 2 for A549, HCT-116, HeLa, <t>SK-MEL-5</t> and n = 3 for MCF7 and PC-3 by two-tailed unpaired t test). Data are represented as the mean value ± SEM. (C) Aggregation of A56 CAR-T cells targeting tumor cells observed every 12 h until day 4 in real-time. (D) Antigen-dependent anti-tumor efficacy of A56 CAR-T cells in HCT-116 tumor-bearing mice after intratumoral T cell injection following OTS-412 injection with or without HU (∗ p < 0.05, ∗∗ p < 0.01, comparison of T cell groups; saline, n = 5; treatment groups, n = 4, two-way ANOVA with multiple comparison). Data are represented as the mean value ± SD. (E) IHC analysis of A56 expression and infiltrated hCD3 + T cells in tumors isolated from HCT-116 tumor-bearing mice 21 days post-intravenous T cell treatment. Scale bar, 20 μm (left panel) and quantitation of tumor-infiltrating A56 CAR-T cells positive for hCD3 (right panel) (∗ p = 0.01, n = 3, two-tailed unpaired t test). Data are presented as the mean ± SD. MOI, multiplicity of infection; IHC, immunohistochemistry.
Human Malignant Melanoma Cell Lines, supplied by North American Biologicals Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human malignant melanoma cell lines/product/North American Biologicals Inc
Average 90 stars, based on 1 article reviews
human malignant melanoma cell lines - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
human malignant melanoma cell line rvh421  (Johns Hopkins HealthCare)
90
Johns Hopkins HealthCare human malignant melanoma cell line rvh421
In vitro and in vivo functionality of A56-specific A56 CAR-T cells (A) Real-time cytotoxicity of A56 CAR-T cells against HCT-116 cells infected with 0.05 MOI of OTS-412. (B) Quantification of A56 CAR-T cell cytotoxicity in various human cancer cell lines infected with OTS-412. (∗∗∗ p < 0.001, comparison of T cell groups; n = 2 for A549, HCT-116, HeLa, <t>SK-MEL-5</t> and n = 3 for MCF7 and PC-3 by two-tailed unpaired t test). Data are represented as the mean value ± SEM. (C) Aggregation of A56 CAR-T cells targeting tumor cells observed every 12 h until day 4 in real-time. (D) Antigen-dependent anti-tumor efficacy of A56 CAR-T cells in HCT-116 tumor-bearing mice after intratumoral T cell injection following OTS-412 injection with or without HU (∗ p < 0.05, ∗∗ p < 0.01, comparison of T cell groups; saline, n = 5; treatment groups, n = 4, two-way ANOVA with multiple comparison). Data are represented as the mean value ± SD. (E) IHC analysis of A56 expression and infiltrated hCD3 + T cells in tumors isolated from HCT-116 tumor-bearing mice 21 days post-intravenous T cell treatment. Scale bar, 20 μm (left panel) and quantitation of tumor-infiltrating A56 CAR-T cells positive for hCD3 (right panel) (∗ p = 0.01, n = 3, two-tailed unpaired t test). Data are presented as the mean ± SD. MOI, multiplicity of infection; IHC, immunohistochemistry.
Human Malignant Melanoma Cell Line Rvh421, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human malignant melanoma cell line rvh421/product/Johns Hopkins HealthCare
Average 90 stars, based on 1 article reviews
human malignant melanoma cell line rvh421 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
human malignant melanoma sk-mel-28 cell line  (Procell Inc)
90
Procell Inc human malignant melanoma sk-mel-28 cell line
In vitro and in vivo functionality of A56-specific A56 CAR-T cells (A) Real-time cytotoxicity of A56 CAR-T cells against HCT-116 cells infected with 0.05 MOI of OTS-412. (B) Quantification of A56 CAR-T cell cytotoxicity in various human cancer cell lines infected with OTS-412. (∗∗∗ p < 0.001, comparison of T cell groups; n = 2 for A549, HCT-116, HeLa, <t>SK-MEL-5</t> and n = 3 for MCF7 and PC-3 by two-tailed unpaired t test). Data are represented as the mean value ± SEM. (C) Aggregation of A56 CAR-T cells targeting tumor cells observed every 12 h until day 4 in real-time. (D) Antigen-dependent anti-tumor efficacy of A56 CAR-T cells in HCT-116 tumor-bearing mice after intratumoral T cell injection following OTS-412 injection with or without HU (∗ p < 0.05, ∗∗ p < 0.01, comparison of T cell groups; saline, n = 5; treatment groups, n = 4, two-way ANOVA with multiple comparison). Data are represented as the mean value ± SD. (E) IHC analysis of A56 expression and infiltrated hCD3 + T cells in tumors isolated from HCT-116 tumor-bearing mice 21 days post-intravenous T cell treatment. Scale bar, 20 μm (left panel) and quantitation of tumor-infiltrating A56 CAR-T cells positive for hCD3 (right panel) (∗ p = 0.01, n = 3, two-tailed unpaired t test). Data are presented as the mean ± SD. MOI, multiplicity of infection; IHC, immunohistochemistry.
Human Malignant Melanoma Sk Mel 28 Cell Line, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human malignant melanoma sk-mel-28 cell line/product/Procell Inc
Average 90 stars, based on 1 article reviews
human malignant melanoma sk-mel-28 cell line - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Specificity of Enrichment of PolyLacNAc-Containing Glycopeptide of Anion Exchange Columns from A375 Cell Lysates <xref ref-type= a " width="100%" height="100%">

Journal: Analytical Chemistry

Article Title: Mass Spectrometry Analysis of Glycopeptides Enriched by Anion Exchange-Mediated Methods Reveals PolyLacNAc-Extended N -Glycans in Integrins and Tetraspanins in Melanoma Cells

doi: 10.1021/acs.analchem.3c04045

Figure Lengend Snippet: Specificity of Enrichment of PolyLacNAc-Containing Glycopeptide of Anion Exchange Columns from A375 Cell Lysates a

Article Snippet: The A375 malignant melanoma cell line was purchased from Ubigene (Brooklyn, NY).

Techniques:

In vitro and in vivo functionality of A56-specific A56 CAR-T cells (A) Real-time cytotoxicity of A56 CAR-T cells against HCT-116 cells infected with 0.05 MOI of OTS-412. (B) Quantification of A56 CAR-T cell cytotoxicity in various human cancer cell lines infected with OTS-412. (∗∗∗ p < 0.001, comparison of T cell groups; n = 2 for A549, HCT-116, HeLa, SK-MEL-5 and n = 3 for MCF7 and PC-3 by two-tailed unpaired t test). Data are represented as the mean value ± SEM. (C) Aggregation of A56 CAR-T cells targeting tumor cells observed every 12 h until day 4 in real-time. (D) Antigen-dependent anti-tumor efficacy of A56 CAR-T cells in HCT-116 tumor-bearing mice after intratumoral T cell injection following OTS-412 injection with or without HU (∗ p < 0.05, ∗∗ p < 0.01, comparison of T cell groups; saline, n = 5; treatment groups, n = 4, two-way ANOVA with multiple comparison). Data are represented as the mean value ± SD. (E) IHC analysis of A56 expression and infiltrated hCD3 + T cells in tumors isolated from HCT-116 tumor-bearing mice 21 days post-intravenous T cell treatment. Scale bar, 20 μm (left panel) and quantitation of tumor-infiltrating A56 CAR-T cells positive for hCD3 (right panel) (∗ p = 0.01, n = 3, two-tailed unpaired t test). Data are presented as the mean ± SD. MOI, multiplicity of infection; IHC, immunohistochemistry.

Journal: iScience

Article Title: Development of chimeric antigen receptor (CAR)-T cells targeting A56 viral protein implanted by oncolytic virus

doi: 10.1016/j.isci.2024.109256

Figure Lengend Snippet: In vitro and in vivo functionality of A56-specific A56 CAR-T cells (A) Real-time cytotoxicity of A56 CAR-T cells against HCT-116 cells infected with 0.05 MOI of OTS-412. (B) Quantification of A56 CAR-T cell cytotoxicity in various human cancer cell lines infected with OTS-412. (∗∗∗ p < 0.001, comparison of T cell groups; n = 2 for A549, HCT-116, HeLa, SK-MEL-5 and n = 3 for MCF7 and PC-3 by two-tailed unpaired t test). Data are represented as the mean value ± SEM. (C) Aggregation of A56 CAR-T cells targeting tumor cells observed every 12 h until day 4 in real-time. (D) Antigen-dependent anti-tumor efficacy of A56 CAR-T cells in HCT-116 tumor-bearing mice after intratumoral T cell injection following OTS-412 injection with or without HU (∗ p < 0.05, ∗∗ p < 0.01, comparison of T cell groups; saline, n = 5; treatment groups, n = 4, two-way ANOVA with multiple comparison). Data are represented as the mean value ± SD. (E) IHC analysis of A56 expression and infiltrated hCD3 + T cells in tumors isolated from HCT-116 tumor-bearing mice 21 days post-intravenous T cell treatment. Scale bar, 20 μm (left panel) and quantitation of tumor-infiltrating A56 CAR-T cells positive for hCD3 (right panel) (∗ p = 0.01, n = 3, two-tailed unpaired t test). Data are presented as the mean ± SD. MOI, multiplicity of infection; IHC, immunohistochemistry.

Article Snippet: HeLa (cervical carcinoma; ATCC) and SK-MEL-5 (malignant melanoma; KCLB) human cell lines were cultured in 10% FBS-DMEM medium (HyClone).

Techniques: In Vitro, In Vivo, Infection, Comparison, Two Tailed Test, Injection, Saline, Expressing, Isolation, Quantitation Assay, Immunohistochemistry